Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-17 06:04 am Purchase |
2023-03-09 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 3,644,573 5.000% |
766,276 (+26.62%) |
Filing History |
| 2023-02-14 08:27 am Sale |
2022-12-31 | 13G | Beam Therapeutics Inc. BEAM |
FARALLON CAPITAL PARTNERS LP | 3,399,921 4.800% |
-151,850 (-4.28%) |
Filing History |
| 2023-02-10 11:48 am Purchase |
2022-12-31 | 13G | Beam Therapeutics Inc. BEAM |
ARK Investment Management LLC | 8,213,131 11.650% |
229,730 (+2.88%) |
Filing History |
| 2023-02-10 06:10 am Sale |
2022-12-31 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 2,878,297 4.100% |
-1,080,915 (-27.30%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Beam Therapeutics Inc. BEAM |
The Vanguard Group | 6,273,630 8.900% |
1,576,365 (+33.56%) |
Filing History |
| 2023-02-09 08:14 am Purchase |
2023-02-09 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 7,769,016 11.024% |
1,779,318 (+29.71%) |
Filing History |
| 2023-02-02 4:05 pm Purchase |
2022-12-31 | 13G | Beam Therapeutics Inc. BEAM |
BLACKROCK INC BLK |
5,238,280 7.400% |
1,175,486 (+28.93%) |
Filing History |
| 2022-07-14 3:55 pm Purchase |
2022-07-05 | 13G | Beam Therapeutics Inc. BEAM |
FARALLON CAPITAL PARTNERS LP | 3,551,771 5.100% |
3,551,771 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
Redmile Group LLC | 1,885,850 2.800% |
-1,892,412 (-50.09%) |
Filing History |
| 2022-02-14 4:04 pm Sale |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
HHLR Advisors, Ltd. | 0 0.000% |
-2,966,403 (Position Closed) |
Filing History |
| 2022-02-14 12:04 pm Sale |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
ARCH Venture Fund IX, L.P. | 5,871,150 8.600% |
-2,371,889 (-28.77%) |
Filing History |
| 2022-02-14 06:38 am Purchase |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 3,959,212 5.800% |
604,571 (+18.02%) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
The Vanguard Group | 4,697,265 6.890% |
4,697,265 (New Position) |
Filing History |
| 2022-02-09 2:05 pm Purchase |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
ARK Investment Management LLC | 7,983,401 11.720% |
1,676,852 (+26.59%) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 5,989,698 8.790% |
-828,724 (-12.15%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
BLACKROCK INC BLK |
4,062,794 6.000% |
970,983 (+31.40%) |
Filing History |
| 2022-01-24 08:40 am Sale |
2022-01-21 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 6,818,422 10.007% |
-510,164 (-6.96%) |
Filing History |
| 2021-06-10 1:14 pm Purchase |
2021-05-31 | 13G | Beam Therapeutics Inc. BEAM |
ARK Investment Management LLC | 6,306,549 10.080% |
6,306,549 (New Position) |
Filing History |
| 2021-04-09 6:02 pm Sale |
2021-03-31 | 13G | Beam Therapeutics Inc. BEAM |
BLACKROCK INC BLK |
3,091,811 5.000% |
-67,699 (-2.14%) |
Filing History |
| 2021-02-16 4:18 pm Purchase |
2020-12-31 | 13G | Beam Therapeutics Inc. BEAM |
HHLR Advisors, Ltd. | 2,966,403 5.100% |
2,966,403 (New Position) |
Filing History |